32
Nanomedicine in a Nanominute:
A Market Brief
Bill Martineau, MBA, predicts that all five
groups of nanomedicines, spurred by expanding
indications and a continuing flow of new
products into the marketplace, will record strong
growth in demand throughout the next decade
and beyond.
36
Proteins & Peptides: Dependent on
Advances in Drug Delivery?
Contributor Cindy H. Dubin talks with some of the
industry's leading protein and peptide
manufacturers about how new drug delivery
systems will improve next-generation drugs.
42
From Battlefield to Backpack:
Evolution of the Auto-Injector
Mike Mesa, using his company’s historical
perspective, indicates that as auto-injectors
continue to evolve, their safety, reliability,
durability, and ease of use will remain critical
considerations for researchers, physicians, and
end-users.
50
Drug Delivery Technology March 2009 Vol 9 No 3
“The increased use, development, and
discovery of protein therapeutics will lead to
increasing opportunities for drug delivery
companies. Pharma companies need to use
these technologies to gain a competitive edge
in an increasingly crowded therapeutic protein
market. The protein therapeutic market is
largely immediate release, but there is a
trend moving toward increased sustained-
release formulations.”
6
p. 36
A New Approach to Threshold
Evaluation & Quantitation of
Unknown Extractables &
Leachables Using HPLC/CAD
Xiaochun Yu, PhD, Steve Zdravkovic, Derek
Wood, Chunyu Li, Yufei Cheng, PhD, and Xiaoya
Ding, PhD, provide a case study involving the
evaluation of the extractables of an elastomeric
packaging component to demonstrate one of the
